The evidence for GLP-1 medications in treating NASH (the more severe form of fatty liver disease) is particularly impressive: Liraglutide achieved histological resolution of steatohepatitis in 39% of cases after 48 weeks, compared to just 9% in placebo groups 20 Patients taking liraglutide had 4.5 times higher likelihood of NASH resolution than those on placebo 20 Semaglutide demonstrated NASH resolution in 59% of participants versus 17% in placebo groups 21 We offer FibroScan technology to measure liver stiffness and fat content, helping us monitor your progress while on GLP-1 therapy
Together, these peptides optimize sleep, preserve telomeres, reduce stress-induced damage, and improve cognitive function
- Premium upholstery materials for commercial use
Here are some reputable online platforms that sell semaglutide, tirzepatide, or both: Because GLP-1 RAs are prescription medications, each of the above platforms employs licensed medical professionals to conduct consultations with prospective patients
When lifestyle measures prove insufficient, laxatives may be appropriate: Osmotic laxatives (macrogol/polyethylene glycol preparations) are often considered first-line for chronic constipation